au moment de l'échec virologique, était en moyenne de 155 ± 123 copies/ml (Minimum : 45 -Maximum 391) ,
Découvertes de séropositivité VIH et sida -France, pp.9-10154, 2003. ,
Enhanced CD4+ T-Cell Recovery with Earlier HIV-1 Antiretroviral Therapy, New England Journal of Medicine, vol.368, issue.3, pp.218-230, 2013. ,
DOI : 10.1056/NEJMoa1110187
The undiagnosed HIV epidemic in ,
The early years of HIV research: integrating clinical and basic research, Nature Medicine, vol.9, issue.7 ,
DOI : 10.1038/nm0703-844
Role of viral regulatory and accessory proteins in HIV-1 replication, Frontiers in Bioscience, vol.9, issue.1-3, pp.2388-2413, 2004. ,
DOI : 10.2741/1403
Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase, Journal of virology, issue.8, pp.695087-5094, 1995. ,
High Rate of Recombination throughout the Human Immunodeficiency Virus Type 1 Genome, Journal of Virology, vol.74, issue.3, pp.1234-1240, 2000. ,
DOI : 10.1128/JVI.74.3.1234-1240.2000
Sanctuary sites in HIV-1 infection, Antiviral therapy, vol.3, issue.4, pp.13-17, 1998. ,
A new human immunodeficiency virus derived from gorillas, Nature Medicine, vol.24, issue.8, pp.871-872, 2009. ,
DOI : 10.1038/nm.2016
Molecular epidemiology of HIV. The Indian journal of medical research, pp.333-344, 2005. ,
Global epidemiology of HIV, Journal of Medical Virology, vol.20, issue.S1, pp.7-12, 2006. ,
DOI : 10.1002/jmv.20599
Diagnosis and Monitoring of HIV-1 Group O-Infected Patients in Cameroun, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.53, issue.1, pp.107-110, 2010. ,
DOI : 10.1097/QAI.0b013e3181b97ec1
Confirmation of Putative HIV-1 Group P in Cameroon, Journal of Virology, vol.85, issue.3, pp.1403-1407, 2011. ,
DOI : 10.1128/JVI.02005-10
An overview of intracellular interactions between immunodeficiency viruses and their hosts, AIDS, vol.26, issue.10, pp.1243-1254 ,
DOI : 10.1097/QAD.0b013e328353bd04
Host factors mediating HIV-1 replication. Virus research, pp.101-114, 2011. ,
DOI : 10.1016/j.virusres.2011.08.001
Host factors exploited by retroviruses, Nature Reviews Microbiology, vol.100, issue.4, pp.253-263, 2007. ,
DOI : 10.1038/nrmicro1541
Revisiting HIV-1 uncoating, Retrovirology, vol.7, issue.1, pp.96-122, 2006. ,
DOI : 10.1186/1742-4690-7-96
URL : http://doi.org/10.1186/1742-4690-7-96
HIV: Dendritic cells as embers for the infectious fire, Current Biology, vol.6, issue.6, pp.655-657, 1996. ,
DOI : 10.1016/S0960-9822(09)00441-2
Épidémiologie, transmission et prévention de l'infection à VIH. EMC -Maladies infectieuses, pp.1-10, 2011. ,
Increased risk of myocardial infarction in HIV-infected patients in France, relative to the general population, AIDS, vol.24, issue.8, pp.241228-1230 ,
DOI : 10.1097/QAD.0b013e328339192f
Role of traditional risk factors and antiretroviral drugs in the incidence of chronic kidney disease, PloS One, vol.8, issue.6, pp.2004-2012, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-01101114
The spectrum of malignancies in HIV-infected patients in 2006 in France: The ONCOVIH study, International Journal of Cancer, vol.45, issue.2, pp.467-475, 2011. ,
DOI : 10.1002/ijc.25903
Cognitive disorders in HIV-infected patients, AIDS, vol.27, issue.3, pp.391-400 ,
DOI : 10.1097/QAD.0b013e32835b1019
URL : https://hal.archives-ouvertes.fr/hal-01101101
Causes of death among HIV-infected patients in France in 2010 (national survey), AIDS, vol.28, issue.8, pp.281181-1191, 2000. ,
DOI : 10.1097/QAD.0000000000000222
The Future of HIV Testing, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.55, issue.2, pp.102-107, 2010. ,
DOI : 10.1097/QAI.0b013e3181fbca44
Evaluation of the sensitivity and specificity of six HIV combined p24 antigen and antibody assays, Journal of Virological Methods, vol.122, issue.2, pp.185-194, 2004. ,
DOI : 10.1016/j.jviromet.2004.08.018
One or two enzymelinked immunosorbent assay tests on the first serum sample for initial diagnosis of HIV-1 infection? AIDS Performances of four fourthgeneration human immunodeficiency virus-1 screening assays, Journal of medical virology, vol.22, issue.8412, pp.2042-20441884, 2008. ,
Assessment of the ability of a fourth-generation immunoassay for human immunodeficiency virus (HIV) antibody and p24 antigen to detect both acute and recent HIV infections in a high-risk setting AIDS: proposed WHO criteria for interpreting western blot assays for HIV-1, HIV-2, and HTLV-I/HTLV-II. Bulletin of the World Health Organization, Journal of clinical microbiology, vol.40, issue.691, pp.472639-2642127, 1991. ,
infection due au VIH chez les sujets âgés de plus de 18 mois (à l'exclusion du dépistage sur les dons de sang et chez les donneurs d'organes ou de tissus) http://www.has-sante.fr/portail/jcms/c_271991/fr/strategies-du-diagnostic-biologique-de-l- infection-due-au-vih-chez-les-sujets-ages-de-plus-de-18-mois-a-l-exclusion ,
has-sante.fr/portail/jcms/c_866949/fr/depistage-de-linfection-par-le-vih-en-france- strategies-et-dispositif-de-depistage?xtmc=&xtcr=1 43 Arrêté du 28 mai 2010 fixant les conditions de réalisation du diagnostic biologique de l'infection à virus de l'immunodéficience humaine (VIH 1 et 2) et les conditions de réalisation du test rapide d'orientation diagnostique dans les situations d'urgence http ,
Surveillance VIH -Sida Région Haute-Normandie, Point Épidémiologique, vol.2012, pp.1-4 ,
Factors associated with acute HIV infection diagnosis in MSM, ANRS-Opportunity study, PloS One, vol.2012, issue.72, pp.31695-31742, 2013. ,
Clinical, virological and immunological features of primary HIV-1 infection. Genitourinary medicine Symptomatic primary infection due to human immunodeficiency virus type 1: review of 31, pp.367-373, 1991. ,
Comparison of Clinical Features of Acute HIV-1 Infection in Patients Infected Sexually or Through Injection Drug Use, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.24, issue.5, pp.425-432, 2000. ,
DOI : 10.1097/00126334-200008150-00004
Acute AIDS retrovirus infection. Definition of a clinical illness associated with seroconversion, Lancet, vol.1, issue.8428, pp.537-540, 1985. ,
DOI : 10.1016/s0140-6736(85)91205-x
Clinical picture of primary HIV infection presenting as a glandular-fever-like illness., BMJ, vol.297, issue.6660, pp.2971363-1368, 1988. ,
DOI : 10.1136/bmj.297.6660.1363
Diagnosis of Human Immunodeficiency Virus Infection in Seronegative Homosexuals Presenting With an Acute Viral Syndrome, JAMA: The Journal of the American Medical Association, vol.258, issue.9, pp.1196-1199, 1987. ,
DOI : 10.1001/jama.1987.03400090080038
Oral manifestations of HIV infection. Annals of internal medicine, pp.485-496, 1996. ,
Esophageal candidiasis associated with acute infection due to human immunodeficiency virus Clinical infectious diseases : an official publication of the Infectious Diseases Society of America Guillain-Barré syndrome as an early manifestation of HIV central nervous system infection. Scandinavian journal of infectious diseases, pp.791-59, 1986. ,
Influence of neurologic manifestations of primary human immunodeficiency virus infection on disease progression. SEROCO Study Group. The Journal of infectious diseases, pp.1711190-1195, 1995. ,
Acute myelopathy associated with primary infection with human immunodeficiency virus., BMJ, vol.294, issue.6565, pp.143-144, 1987. ,
DOI : 10.1136/bmj.294.6565.143
Characterization of T lymphocyte responses during primary infection with human immunodeficiency virus. The Journal of infectious diseases, pp.889-896, 1988. ,
Immunological changes in primary HIV-1 infection, AIDS, vol.4, issue.10, pp.995-999, 1990. ,
DOI : 10.1097/00002030-199010000-00008
Effects of primary HIV-1 infection on subsets of CD4+ and CD8+ T lymphocytes, AIDS, vol.9, issue.6, pp.561-566, 1995. ,
DOI : 10.1097/00002030-199506000-00005
Correlation between immunologic function and clinical subpopulations of patients with the acquired immune deficiency syndrome. The American journal of medicine Risk of developing AIDS after primary acute HIV-1 infection, Journal of acquired immune deficiency syndromes, vol.78, issue.66, pp.417-422575, 1985. ,
Does symptomatic primary HIV-1 ,
Acute HIV-1 Infection, New England Journal of Medicine, vol.364, issue.20, pp.1943-1954, 2011. ,
DOI : 10.1056/NEJMra1011874
Propagation and dissemination of infection after vaginal transmission of simian immunodeficiency virus, Journal of virology, issue.14, pp.799217-9227, 2005. ,
Sexual Transmission and Propagation of SIV and HIV in Resting and Activated CD4+ T Cells, Science, vol.286, issue.5443, pp.1353-1357, 1999. ,
DOI : 10.1126/science.286.5443.1353
Visualizing Antigen-Specific and Infected Cells in Situ Predicts Outcomes in Early Viral Infection, Science, vol.323, issue.5922, pp.3231726-1729, 2009. ,
DOI : 10.1126/science.1168676
The role of sexually transmitted diseases in HIV transmission, Nature Reviews Microbiology, vol.14, issue.1 ,
DOI : 10.1097/00007435-200003000-00004
Transcytosis of infectious human immunodeficiency virus across a tight human epithelial cell line barrier, Nature Medicine, vol.98, issue.1, pp.42-47, 1997. ,
DOI : 10.1083/jcb.113.2.275
Endocytic Traffic in Polarized Epithelial Cells: Role of the Actin and Microtubule Cytoskeleton, Traffic, vol.1, issue.3, pp.149-159, 2001. ,
DOI : 10.1034/j.1600-0854.2001.020301.x
DC-SIGN, a Dendritic Cell???Specific HIV-1-Binding Protein that Enhances trans-Infection of T Cells, Cell, vol.100, issue.5, pp.587-597, 2000. ,
DOI : 10.1016/S0092-8674(00)80694-7
The Role of DC-SIGN and DC-SIGNR in HIV and SIV Attachment, Infection, and Transmission, Virology, vol.286, issue.1, pp.1-6, 2001. ,
DOI : 10.1006/viro.2001.0975
Simian Immunodeficiency Virus Rapidly Penetrates the Cervicovaginal Mucosa after Intravaginal Inoculation and Infects Intraepithelial Dendritic Cells, Journal of Virology, vol.74, issue.13, pp.746087-6095, 2000. ,
DOI : 10.1128/JVI.74.13.6087-6095.2000
Early events in sexual transmission of HIV and SIV and opportunities for interventions. Annual review of medicine, pp.127-139, 2011. ,
The immune response during acute HIV-1 infection: clues for vaccine development, Nature Reviews Immunology, vol.9, issue.1, pp.11-23, 2010. ,
DOI : 10.1038/nri2674
Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection, Nature, vol.82, issue.7037, pp.4341093-1097, 2005. ,
DOI : 10.1084/jem.164.1.280
Induction of a Striking Systemic Cytokine Cascade prior to Peak Viremia in Acute Human Immunodeficiency Virus Type 1 Infection, in Contrast to More Modest and Delayed Responses in Acute Hepatitis B and C Virus Infections, Journal of Virology, vol.83, issue.8, pp.833719-3733, 2009. ,
DOI : 10.1128/JVI.01844-08
Primary infection with simian immunodeficiency virus: plasmacytoid dendritic cell homing to lymph nodes, type I interferon, and immune suppression, Blood, vol.112, issue.12, pp.1124598-4608, 2008. ,
DOI : 10.1182/blood-2008-06-162651
URL : https://hal.archives-ouvertes.fr/hal-00345337
Evolution of innate and adaptive effector cell functions during acute HIV-1 infection. The Journal of infectious diseases, pp.1951452-1460, 2007. ,
Innate immune responses in primary HIV-1 infection. Current opinion in HIV and AIDS, pp.36-44, 2008. ,
HIV modulates the expression of ligands important in triggering natural killer cell cytotoxic responses on infected primary T-cell blasts, Blood, vol.110, issue.4, pp.1207-1214, 2007. ,
DOI : 10.1182/blood-2006-06-028175
Rapid evolution of the neutralizing antibody response to HIV type 1 infection, Proceedings of the National Academy of Sciences, vol.100, issue.7, pp.4144-4149, 2003. ,
DOI : 10.1073/pnas.0630530100
Neutralizing Antibody Responses in Acute Human Immunodeficiency Virus Type 1 Subtype C Infection, Journal of Virology, vol.81, issue.12, pp.816187-6196, 2007. ,
DOI : 10.1128/JVI.00239-07
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1900112
In Vivo Depletion of CD11c+ Dendritic Cells Abrogates Priming of CD8+ T Cells by Exogenous Cell-Associated Antigens, Immunity, vol.17, issue.2, pp.211-220, 2002. ,
DOI : 10.1016/S1074-7613(02)00365-5
Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection, Nature, vol.387, issue.6629, pp.387183-188, 1997. ,
DOI : 10.1038/387183a0
The Challenge of Viral Reservoirs in Hiv ,
Comparative Analysis of Measures of Viral Reservoirs in HIV-1 Eradication Studies, PLoS Pathogens, vol.108, issue.2, p.1003174 ,
DOI : 10.1371/journal.ppat.1003174.t004
In vivo estimates of division and death rates of human T lymphocytes., Proceedings of the National Academy of Sciences, vol.92, issue.9, pp.3707-3711, 1995. ,
DOI : 10.1073/pnas.92.9.3707
In vivo fate of HIV-1-infected T cells: Quantitative analysis of the transition to stable latency, Nature Medicine, vol.4, issue.12, pp.1284-1290, 1995. ,
DOI : 10.1038/373117a0
Induction of HIV-1 Replication in Latently Infected CD4+ T Cells Using a Combination of Cytokines. The Journal of experimental medicine, p.83, 1998. ,
Proviral HIV-1 DNA in subjects followed since primary HIV-1 infection who suppress plasma viral load after one year of highly active antiretroviral therapy, AIDS, vol.15, issue.6, pp.15665-673, 2001. ,
DOI : 10.1097/00002030-200104130-00001
HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation, Nature Medicine, vol.45, issue.8, pp.15893-900, 2009. ,
DOI : 10.1038/nm.1972
Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS, Nature, vol.362, issue.6418, pp.362359-362, 1993. ,
DOI : 10.1038/362359a0
Infection frequency of dendritic cells and CD4+ T lymphocytes in spleens of human immunodeficiency virus-positive patients, Journal of virology, issue.8, p.694737, 1995. ,
Mechanisms of Gastrointestinal CD4+ T-Cell Depletion during Acute and Early Human Immunodeficiency Virus Type 1 Infection, Journal of Virology, vol.81, issue.2, pp.599-612, 2007. ,
DOI : 10.1128/JVI.01739-06
Damaged Intestinal Epithelial Integrity Linked to Microbial Translocation in Pathogenic Simian Immunodeficiency Virus Infections, PLoS Pathogens, vol.434, issue.8, p.1001052, 2010. ,
DOI : 10.1371/journal.ppat.1001052.s011
Neuropathologic Contributions to Understanding AIDS and the Central Nervous System, Brain Pathology, vol.2, issue.2, pp.197-208, 2007. ,
DOI : 10.1002/ana.410200316
Early levels of HIV-1 DNA in peripheral blood mononuclear cells are predictive of disease progression independently of HIV-1 RNA levels and CD4+ T cell counts. The Journal of infectious diseases, pp.46-55, 2005. ,
HIV-1 DNA for the measurement of the HIV reservoir is predictive of disease progression in seroconverters whatever the mode of result expression is Journal of clinical virology: the official publication of the Pan American Society for Clinical Virology, pp.399-404, 2008. ,
CD4 cell count and HIV DNA level are independent predictors of disease progression after primary HIV type 1 ,
Immune responses driven by protective human leukocyte antigen alleles from long-term nonprogressors are associated with low HIV reservoir in central memory CD4 T cells. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, pp.541495-1503, 2012. ,
Human immunodeficiency virus type 1 long-term nonprogressors: the viral, genetic and immunological basis for disease non-progression. The Journal of general virology, pp.92247-268, 2011. ,
Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study, PLoS Pathogens, vol.22, issue.16, p.1003211 ,
DOI : 10.1371/journal.ppat.1003211.s007
Prevention of HIV-1 Infection with Early Antiretroviral Therapy, New England Journal of Medicine, vol.365, issue.6, pp.365493-505, 2011. ,
DOI : 10.1056/NEJMoa1105243
Guidelines Version 7.0, 2013. ,
Antiretroviral Treatment of Adult HIV Infection, JAMA, vol.312, issue.4, pp.312410-425 ,
DOI : 10.1001/jama.2014.8722
A Controlled Trial of Zidovudine in Primary Human Immunodeficiency Virus Infection, New England Journal of Medicine, vol.333, issue.7, pp.333408-413, 1995. ,
DOI : 10.1056/NEJM199508173330702
Zidovudine Treatment in Patients with Primary (Acute) Human Immunodeficiency Virus Type 1 Infection: A Randomized, Double-Blind, Placebo-Controlled Trial, Journal of Infectious Diseases, vol.178, issue.1, pp.80-91, 1998. ,
DOI : 10.1086/515612
Reduced viremia and increased CD4/CD8 ratio in patients with primary HIV infection treated with AZTddI, 1996. ,
A triple nucleoside analogue combination in four patient with primary HIV-1 ,
Effects of a combination of zidovudine, didanosine, and lamivudine on primary human immunodeficiency virus type 1 infection. The Journal of infectious diseases, pp.1051-1055, 1997. ,
Triple therapy with AZT, 3TC and ritonavir in 12 subjects newly infected with HIV-1. Abstract ThB933, Eleventh International Conference on AIDS, 1996. ,
Treatment of Primary Human Immunodeficiency Virus Type 1 Infection with Potent Antiretroviral Therapy Reduces Frequency of Rapid Progression to AIDS, The Journal of Infectious Diseases, vol.183, issue.10, pp.1831466-1475, 2001. ,
DOI : 10.1086/320189
Immunological and virological impact of highly active antiretroviral therapy initiated during acute HIV-1 infection. The Journal of infectious diseases, pp.734-739, 2006. ,
The Setpoint Study (ACTG A5217): Effect of Immediate Versus Deferred Antiretroviral Therapy on Virologic Set Point in Recently HIV-1-Infected Individuals, Journal of Infectious Diseases, vol.205, issue.1, pp.87-96 ,
DOI : 10.1093/infdis/jir699
Predictors of virological outcome and safety in primary HIV type 1-infected patients initiating quadruple antiretroviral therapy: QUEST GW PROB3005. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, pp.45381-390, 2007. ,
URL : https://hal.archives-ouvertes.fr/hal-00465353
Short-Course Antiretroviral Therapy in Primary HIV Infection, New England Journal of Medicine, vol.368, issue.3, pp.207-217, 2013. ,
DOI : 10.1056/NEJMoa1110039
Simultaneous determination of 17 antiretroviral drugs in human plasma for quantitative analysis with liquid chromatography???tandem mass spectrometry, Biomedical Chromatography, vol.328, issue.10, pp.1095-1104, 2007. ,
DOI : 10.1002/bmc.865
Increasing HIV- 1 non-B subtype primary infections in patients in France and effect of HIV subtypes on virological and immunological responses to combined antiretroviral therapy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, pp.56880-887, 2013. ,
Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of inductionmaintenance therapy, Trilège ,
The optiprim-ANRS 147 trial Group. Paradoxical impact of maraviroc/raltegravir added to HAART in acute HIV infection: ANRS 147 trial, Conférence on Retroviruses and Opportunistic Infections, 2014. ,
emtricitabine as part of combination regimens for initial treatment of HIV: final results.The Journal of infectious diseases, pp.1191-1201, 2011. ,
Randomized, double-blind, placebo-matched, multicenter trial of abacavir/lamivudine or tenofovir/emtricitabine with lopinavir/ritonavir for initial HIV treatment, AIDS, vol.23, issue.12, pp.1547-1556, 2009. ,
DOI : 10.1097/QAD.0b013e32832cbcc2
Tenofovir DF, Emtricitabine, and Efavirenz vs. Zidovudine, Lamivudine, and Efavirenz for HIV, New England Journal of Medicine, vol.354, issue.3, pp.251-260, 2006. ,
DOI : 10.1056/NEJMoa051871
Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 48 week efficacy and safety results of the CASTLE study, The Lancet, vol.372, issue.9639, pp.372646-655, 2008. ,
DOI : 10.1016/S0140-6736(08)61081-8
Once-daily atazanavir/ritonavir compared with twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1 ,
Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial, The Lancet, vol.374, issue.9692, pp.374796-806, 2009. ,
DOI : 10.1016/S0140-6736(09)60918-1
Efficacy and Tolerability of Atazanavir, Raltegravir, or Darunavir with FTC/TDF: ACTG A5257. Abstract 85, Conference on Retroviruses and Opportunistic Infections, 2014. ,
Comparer l'efficacité virologique de différents schémas d'ARV instaurés lors de la PI VIH et déterminer les facteurs prédictifs d'échec virologique (EV) à 6 mois de traitement ,
Cinquante-cinq adultes traités dans les 3 mois suivant le diagnostic, entre 2003 et 2013 ont été inclus dans cette analyse rétrospective. L'EV était défini par la 1 ère charge virale VIH plasmatique (CV) ? 40 copies ,
sous 3TC-AZT-EFV. Ces 11 patients avaient une CV initiale moyenne = 4,3.10 6 copies/ml significativement plus élevée que celle des patients en succès virologique (p=0,03) ,
Leur CV était indétectable, en moyenne, à 14 mois de traitement Aucune molécule utilisée pour traiter ces 11 patients n'était touchée par la résistance ni sur le TGRA réalisé lors du diagnostic ni sur celui réalisé au moment de l'EV. Le dosage des ARV au moment de l'EV retrouvait une concentration diminuée d'au moins une molécule chez 2/11 patients. En analyse multivariée, aucun facteur prédictif d'EV (âge, sexe, mode de contamination, origine ethnique, sous-type viral ,